JENNIFER GILL: Open Payments
NPI 1558784124 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 36 payments from 18 companies in 2025. Trend: 2023 $476 · 2024 $1,543 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $138 |
| Daiichi Sankyo Inc. | 4 | $95 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| pharmaand GmbH | 2 | $40 |
| TOLMAR, INC. | 2 | $40 |
| Pharmacosmos Therapeutics Inc. | 1 | $35 |
| Aveo Pharmaceuticals, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
Products named: CAPLYTA, Nubeqa, ENHERTU, INJECTAFER, KEYTRUDA, Rubraca, ELIGARD, MONOFERRIC.
Industry payments across PA — which companies pay providers there.
